Neurostimulation Devices Market Projected to Hit USD 16.56 Billion by 2033, Growing Due to Increasing Prevalence of Neurological and Chronic Pain Disorders – SNS Insider

According to SNS Insider, Neurostimulation Devices Market Growth is Fueled by The Increasing Use of Sophisticated Implantable and Non-Invasive Technologies, Favorable Trends in Reimbursement, And ...
Yahoo

Gwyneth Paltrow and Serena Williams are both fans of neuromodulation – but what is it and how does it work?

Add Yahoo as a preferred source to see more of our stories on Google. At-home neurostimulation devices claim to lessen the symptoms of anxiety and chronic pain (Pulsetto) For most, the idea that you ...

Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...
Everyday Health

How Does the PoNS Neurostimulation Device Help With Walking in MS?

For many people living with multiple sclerosis (MS), walking can become one of the most challenging daily tasks. As many as 3 in 4 people with MS have gait issues caused by factors like loss of muscle ...
Benzinga.com

EXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder Value

On Wednesday, Vivani Medical, Inc. (NASDAQ:VANI) said it intends to spin off Cortigent, Inc., a division that develops brain implant devices to help people recover critical body functions, as an ...
MarketWatch

Neurostimulation Devices Market size is set to grow by USD 6.26 billion from 2023-2027, Rising prevalence of neurological disorders to boost the market growth, Technavio

NEW YORK, July 31, 2024 /PRNewswire/ -- The global neurostimulation devices market size is estimated to grow by USD 6.26 billion from 2023-2027, according to Technavio. The market is estimated to grow ...
Seeking Alpha

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin’s Technology

HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation ...
Medindia

Major Trial Questions ADHD Neurostimulation Device

A 150-child trial found an FDA-cleared ADHD stimulation device did not significantly reduce symptoms, raising concerns over ...
Monthly Prescribing Reference

Modius Sleep, a Neurostimulation Device for Chronic Insomnia, Now Available

Credit: Neurovalens. Modius Sleep is an electrical vestibular nerve stimulator that sends signals to a neural pathway that connects to the hypothalamus. Modius Sleep lowered Insomnia Severity Index by ...
MarketWatch

Nexalin Shares Soar After Neurostimulation Device Boosts Cognitive Performance for Alzheimer's Patients

Shares of Nexalin Technology nearly doubled after the company said its second-generation Sync neurostimulation device can improve cognitive performance and enhance brain network connectivity in ...
Seeking Alpha

Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

HOUSTON, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced ...